2012). To determine the underlying mechanism of the anti-obesity effects, DSP was analyzed by HPLC. TFA was identified as the most abundant active component. Panth et al. (2016) also identified TFA as a phenolic acid in NSP. Hypolipidimic (Senaphan et al. 2015; Naowaboot et al. 2016) and multi-systemic beneficial effects have been described for ferulic acid (Srinivasan et al. 2007). Hence, only TFA was selected for in vitro studies. The gene discussed is DSP; the disease is obesity disorder.